2m 2m 2m 2m 2m 2m 2m
AUNA A (AUNA)
NYSE
$5.09+$0.005 (+0.10%)
Price as of Jun 23, 2026 7:04 PM EDT- N/AMarket Cap
- -18.72%1-Year Change
- Medical Care FacilitiesIndustry
AUNA A (AUNA)
$5.09+$0.005 (+0.10%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | ||
|---|---|---|---|
Income Statement | |||
Total Operating Revenue | 4.4B -0.02% | 4.4B N/A | |
Cost of Revenue | 2.7B +2.28% | 2.7B N/A | |
Gross Profit | 1.7B -3.57% | 1.7B N/A | |
Sales and Marketing Expense | 220.9M +11.84% | 197.5M N/A | |
Research and Development Expense | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | N/A N/A | N/A N/A | |
Total Operating Expenses | N/A N/A | N/A N/A | |
Operating Profit | 625.3M -20.22% | 783.8M N/A | |
Interest Income | N/A N/A | N/A N/A | |
Interest Expense | -17.2M -44.37% | -30.8M N/A | |
Interest Income and Expense and Net | -17.2M -44.37% | -30.8M N/A | |
Total Nonoperating Income and Expense | 43.2M -50.72% | 87.6M N/A | |
Income before Taxes | 110.9M -10.53% | 124.0M N/A | |
Income Taxes | 88.4M +47.70% | 59.8M N/A | |
Extraordinary Items | N/A N/A | N/A N/A | |
Net Income | 110.9M -10.53% | 124.0M N/A | |
Net Income from Continuing Operations Applicable to Common | 110.9M -10.53% | 124.0M N/A | |
Basic EPS and Net Income | 1.32 -19.51% | 1.64 N/A | |
Diluted EPS and Net Income | 1.32 -19.02% | 1.63 N/A | |
Basic Weighted Average Shares | 74.0M +9.92% | 67.3M N/A | |
Diluted Weighted Average Shares | 74.0M +9.92% | 67.3M N/A | |
Balance Sheet | |||
Cash and Cash Equivalents | 335.4M +42.29% | 235.7M N/A | |
Short-Term Investments | 30.2M -69.83% | 100.2M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 365.7M +8.84% | 336.0M N/A | |
Total Current Assets | 1.8B +8.26% | 1.7B N/A | |
Accumulated Depreciation | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 2.3B +0.30% | 2.3B N/A | |
Total Long-Term Assets | 5.5B +1.43% | 5.4B N/A | |
Total Assets | 7.3B +3.07% | 7.1B N/A | |
Income Taxes Payable | N/A N/A | N/A N/A | |
Total Short-Term Debt | 316.3M -51.65% | 654.2M N/A | |
Total Current Liabilities | 1.7B -14.30% | 1.9B N/A | |
Total Long-Term Debt | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 3.9B +10.02% | 3.5B N/A | |
Total Liabilities | 5.5B +1.35% | 5.5B N/A | |
Retained Earnings | -192.6M -29.58% | -273.5M N/A | |
Total Stockholders Equity | 1.8B +8.84% | 1.6B N/A | |
Total Shares Outstanding | 30.1M +0.14% | 30.1M N/A | |
Cash Flow | |||
Cash from Operating Activities | 662.5M -0.90% | 668.5M N/A | |
Capital Expenditures | N/A N/A | N/A N/A | |
Cash from Investing Activities | -80.3M -66.11% | -236.8M N/A | |
Dividends Paid | N/A N/A | N/A N/A | |
Cash from Financing Activities | -487.1M +16.50% | -418.1M N/A | |
Financials Ratio | |||
Gross Margin | 37.94% N/A | N/A N/A | |
Operating Margin | 14.26% N/A | N/A N/A | |
Return on Assets | 1.54% N/A | N/A N/A | |
Return on Equity | 6.54% N/A | N/A N/A | |
Revenue Growth | -0.02% N/A | N/A N/A | |
Current Ratio | 1.11 N/A | N/A N/A | |
Cash Ratio | 0.20 N/A | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow